Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant What is This Site Help Center Crisis
Powered By

Top 4 search results for "Voyxact" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
How Long Can You Live With Proteinuria? Understanding Outlook and Treatment
... Food and Drug Administration Filspari (Sparsentan) — Drugs.com Novartis Receives FDA Accelerated Approval for Fabhalta (Iptacopan), the First and Only Complement Inhibitor for the Reduction of Proteinuria in Primary IgA Nephropathy (IgAN) — Novartis Otsuka Receives FDA Accelerated Approval for VOYXACT (Sibeprenlimab‑szsi) for Reduction of Proteinuria ...
How Long Can You Live With Proteinuria? Understanding Outlook and Treatment
... Food and Drug Administration Filspari (Sparsentan) — Drugs.com Novartis Receives FDA Accelerated Approval for Fabhalta (Iptacopan), the First and Only Complement Inhibitor for the Reduction of Proteinuria in Primary IgA Nephropathy (IgAN) — Novartis Otsuka Receives FDA Accelerated Approval for VOYXACT (Sibeprenlimab‑szsi) for Reduction of Proteinuria ...
IgA Nephropathy Treatment: 6 Keys To Maintaining Renal Function
... Atrasentan is the first medication of its kind approved to treat IgAN.Sibeprenlimab-SzsiSibeprenlimab-szsi (Voyxact) blocks a proliferation-inducing ligand (APRIL). ...
IgA Nephropathy Treatment: 6 Keys To Maintaining Renal Function
... Atrasentan is the first medication of its kind approved to treat IgAN.Sibeprenlimab-SzsiSibeprenlimab-szsi (Voyxact) blocks a proliferation-inducing ligand (APRIL). ...
How To Reduce Protein in Urine: Treatment, Tips, and More
... Sibeprenlimab-szs (Voyxact) — This monoclonal antibody helps prevent the immune system from creating harmful IgA deposits. Sparsentan (Filspári) — This dual-action treatment blocks both endothelin and angiotensin receptors. This helps relax blood vessels in the kidneys, reduce strain on the glomeruli, and lower the amount of protein in the urine. ...
How To Reduce Protein in Urine: Treatment, Tips, and More
... Sibeprenlimab-szs (Voyxact) — This monoclonal antibody helps prevent the immune system from creating harmful IgA deposits. Sparsentan (Filspári) — This dual-action treatment blocks both endothelin and angiotensin receptors. This helps relax blood vessels in the kidneys, reduce strain on the glomeruli, and lower the amount of protein in the urine. ...
IgA Nephropathy Prognosis: 6 Factors That Affect Outcome
... azilsartan, candesartan, irbesartan, and losartan Statins Immunosuppressants, such as corticosteroids and targeted-release budesonide (Tarpeyo) Endothelin A receptor antagonists, including atrasentan (Vanrafia) Dual endothelin and angiotensin-receptor blockers, including sparsentan (Filspari) The anti-APRIL monoclonal antibody sibeprenlimab-szsi (Voyxact ...
IgA Nephropathy Prognosis: 6 Factors That Affect Outcome
... azilsartan, candesartan, irbesartan, and losartan Statins Immunosuppressants, such as corticosteroids and targeted-release budesonide (Tarpeyo) Endothelin A receptor antagonists, including atrasentan (Vanrafia) Dual endothelin and angiotensin-receptor blockers, including sparsentan (Filspari) The anti-APRIL monoclonal antibody sibeprenlimab-szsi (Voyxact ...